Found: 19
Select item for more details and to access through your institution.
The evolving nature of coronary artery disease.
- Published in:
- European Heart Journal, 2011, v. 13, n. suppl_C, p. C14
- By:
- Publication type:
- Article
Identifying needs and opportunities for advancing translational research in cardiovascular disease.
- Published in:
- Cardiovascular Research, 2009, v. 83, n. 3, p. 425, doi. 10.1093/cvr/cvp165
- By:
- Publication type:
- Article
The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Geographic differences in patients with acute myocardial infarction in the PARADISE‐MI trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1228, doi. 10.1002/ejhf.2851
- By:
- Publication type:
- Article
Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: The ESC EORP CICD-LT registry.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 4, p. 432, doi. 10.1177/2047487320912491
- By:
- Publication type:
- Article
Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B-type Natriuretic Peptide in the Emergency Department.
- Published in:
- Academic Emergency Medicine, 2003, v. 10, n. 3, p. 198, doi. 10.1197/aemj.10.3.198
- By:
- Publication type:
- Article
Interleukin‐18 in patients with acute coronary syndromes.
- Published in:
- Clinical Cardiology, 2019, v. 42, n. 12, p. 1202, doi. 10.1002/clc.23274
- By:
- Publication type:
- Article
EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non‐valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study.
- Published in:
- Clinical Cardiology, 2019, v. 42, n. 10, p. 851, doi. 10.1002/clc.23231
- By:
- Publication type:
- Article
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX.
- Published in:
- Clinical Cardiology, 2019, v. 42, n. 9, p. 797, doi. 10.1002/clc.23221
- By:
- Publication type:
- Article
Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: The EQUIP-ACS project protocol and design.
- Published in:
- Trials, 2010, v. 11, p. 1, doi. 10.1186/1745-6215-11-5
- By:
- Publication type:
- Article
Impact of established cardiovascular disease on outcomes in the randomized global leaders trial.
- Published in:
- Catheterization & Cardiovascular Interventions, 2020, v. 96, n. 7, p. 1369, doi. 10.1002/ccd.28649
- By:
- Publication type:
- Article
Clinical relevance of ticagrelor monotherapy following 1‐month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial.
- Published in:
- Catheterization & Cardiovascular Interventions, 2020, v. 96, n. 1, p. 100, doi. 10.1002/ccd.28428
- By:
- Publication type:
- Article
Antiplatelet strategies in acute coronary syndromes: design and methodology of an international collaborative network meta-analysis of randomized controlled trials.
- Published in:
- Minerva Cardiology & Angiology, 2021, v. 69, n. 4, p. 398, doi. 10.23736/S2724-5683.20.05353-0
- By:
- Publication type:
- Article
Management strategies and 5-year outcomes in Polish patients with stable coronary artery disease versus other European countries: data from the CLARIFY registry.
- Published in:
- Polish Archives of Internal Medicine, 2019, v. 129, n. 5, p. 327, doi. 10.20452/pamw.14789
- By:
- Publication type:
- Article
Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus noncardiologists.
- Published in:
- Polish Archives of Internal Medicine, 2017, v. 127, n. 2, p. 107, doi. 10.20452/pamw.3902
- By:
- Publication type:
- Article
256-OR: Substantial Cardiovascular Risk Reduction with Icosapent Ethyl Regardless of Diabetes Status or BMI: REDUCE-IT BMI.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-256-OR
- By:
- Publication type:
- Article
4-LB: Substantial Cardiovascular Benefit from Icosapent Ethyl in Patients with Diabetes: REDUCE-IT DIABETES.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-4-LB
- By:
- Publication type:
- Article
403-P: Impact of Diabetes-Related Factors and Background Antihyperglycemic Therapy on the Efficacy and Safety of Ticagrelor Added to Aspirin: Insights from the THEMIS Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-403-P
- By:
- Publication type:
- Article